Ptc Therapeutics (PTCT) Change in Inventory (2017 - 2025)
Ptc Therapeutics has reported Change in Inventory over the past 9 years, most recently at $26.8 million for Q4 2025.
- Quarterly results put Change in Inventory at $26.8 million for Q4 2025, up 341.56% from a year ago — trailing twelve months through Dec 2025 was $53.9 million (up 974.37% YoY), and the annual figure for FY2025 was $53.9 million, up 974.37%.
- Change in Inventory for Q4 2025 was $26.8 million at Ptc Therapeutics, up from $18.5 million in the prior quarter.
- Over the last five years, Change in Inventory for PTCT hit a ceiling of $26.8 million in Q4 2025 and a floor of -$11.1 million in Q4 2024.
- Median Change in Inventory over the past 5 years was $735500.0 (2021), compared with a mean of $3.0 million.
- Biggest five-year swings in Change in Inventory: crashed 1824.51% in 2021 and later skyrocketed 1504.64% in 2023.
- Ptc Therapeutics' Change in Inventory stood at $676000.0 in 2021, then soared by 772.78% to $5.9 million in 2022, then plummeted by 200.64% to -$5.9 million in 2023, then crashed by 86.7% to -$11.1 million in 2024, then skyrocketed by 341.56% to $26.8 million in 2025.
- The last three reported values for Change in Inventory were $26.8 million (Q4 2025), $18.5 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.